SEC Comment Letter for Advance America, Cash Advance Centers, Inc. (CIK 0001299704) — Nov 9, 2004
Advance America, Cash Advance Centers, Inc. (CIK 0001299704)
Date: Nov. 9, 2004 · CIK: 0001299704 · Accession: 0000000000-04-035890
AI Filing Summary & Sentiment
File numbers found in text: 333-118227
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> September 14, 2004 Mail Stop 0408 By U.S. Mail and facsimile to (917) 777-2896. William M. Webster, IV Chief Executive Officer Advance America, Cash Advance Centers, Inc. 135 North Church Street Spartanburg, SC 29306 Re: Advance America, Cash Advance Centers, Inc. Form S-1 filed August 13, 2004 File No. 333-118227 Dear Mr. Webster: We have reviewed your filing and have the following comments. Where indicated, we think you should revise your document in response to these comments. If you disagree, we will consider your explanation as to why our comment is inapplicable or a revision is unnecessary. Please be as detailed as necessary in your explanation. In some of our comments, we may ask you to provide us with supplemental information so we may better understand your disclosure. After reviewing this information, we may or may not raise additional comments. Please understand that the purpose of our review process is to assist you in your compliance with the applicable disclosure requirements and to enhance the overall disclosure in your filing. We look forward to working with you in these respects. We welcome any questions you may have about our comments or any other aspect of our review. Feel free to call us at the telephone numbers listed at the end of this letter. General comments on your filing 1. We note your disclosure on page 23 that your auditors have determined that you had a "significant deficiency" in your financial reporting and controls. Please identify the specific areas that were highlighted by your auditors, the factual scenarios that underpinned the auditors` findings and the timeline of the events that lead up to your auditors` determination and your responses to the finding. 2. It appears that large portions of your Summary, Risk Factors, Management`s Discussion and Analysis, Business section and the notes to financial statements are repeated verbatim in multiple portions of this document. For example, we note that your risk factors discussing your litigation exposure, beginning on page 14, is identical to your discussion of legal proceedings on page 83. Some of the following comments will deal specifically with concerns regarding the content of your disclosure in these various sections. However, the registration statement should avoid duplicative disclosure when possible and instead tailor the disclosure in the various sections to the purpose that each section serves in the overall disclosure framework of the document. 3. We note that, since the beginning of the 2003 fiscal year, you have paid out approximately $173.2 million to your shareholders and plan to distribute out an additional $9.0 million prior to the offering. We also note on page 31 that you attribute these distributions to the need to provide shareholders with cash to meet their tax obligations under Sub-Chapter S. Please supplementally provide the staff with your analysis as to how you determined that these amounts were necessary to meet the tax obligations of your shareholders. We note that your payouts have increase substantially, on an annualized basis, in each of the past two years, outstripping the growth in your net income over the same period. We also note that after the $50 million distribution and the planned $9.0 million distribution, you will have a capital deficiency. 4. To the extent known, please supplementally advise the staff regarding the percentage of the overall offering amount that you expect will be attributed to the company and to the selling shareholders. 5. We note that the over-allotment option will be granted by both the selling shareholders and by the company. How will the underwriter determine which source of additional shares the underwriter will draw from? Will the allocation be pro-rata? Also, please provide your analysis, with a view towards improved disclosure, as to how the company determined that it did not require additional liquidity and therefore chose to allow the selling shareholders to also provide an over-allotment option. 6. Please confirm that Advance America and its subsidiaries are currently in compliance with all covenants under your debt facilities. If you are not able to confirm this statement, please identify the covenant that you have not complied with, identify the reason for the failure to comply, any communication between the lender and Advance America and steps that you have taken to return to compliance. 7. Include an updated consent of the independent auditors in your next amendment. Summary - page 1 8. As noted above, virtually all of the disclosure in this section appears to be drawn verbatim from disclosure included in the Management`s Discussion and Analysis, Business sections and elsewhere in the document. The summary should contain a brief and balanced discussion of your offering. Revise the summary to comply with the following requirements set forth in the Instruction to paragraph 503(a): * the summary "should not merely repeat the text of the prospectus;" ? the summary "should provide a brief overview of the key aspects of the offering;" ? the summary should "identify" and "highlight" those aspects of the offering that are the "most significant." Release 33-7497 and Staff Legal Bulleting No. 7A, sample comment 28 specify that the summary should not include a lengthy description of the company`s business and business strategy. Rather than repeat disclosures found in the body of the prospectus, substitute cross- references to those prospectus sections including the specific page numbers where those disclosures begin. 9. Please revise the opening paragraph of this section. A summary, by its very nature will not contain all the information that an investor needs to make an investment decision. Consequently, please eliminate the first sentence of this preamble section. 10. The Summary should provide a balanced discussion of your business, including the risks and challenges that stand between your company and its implementation of its growth plan. In particular, we note that the summary does not discuss the risks presented by your agency lending platform, the legal uncertainties that has forced you to suspend your Georgia operations and the costs associated with your growth plan. Please expand your discussion of your business development and your growth strategies to discuss the challenges that confront those plans and your business in general, in a similar level of detail. 11. In this section, consider briefly discussing the lending process, the funding procedures you use to fund your payday loans, and a discussion of the chief differences between the standard and agency business models. 12. Please clarify how you have determined that you are the largest payday lender in the United States. Is your statement based on dollar volume of loans, number of loans or number of offices? 13. Briefly describe the distributions that you will make prior to the offering and disclose the resulting capital position of the company. Competitive Strengths - page 3 14. You state on page 4 that you have significant geographic diversification that helps mitigate the risk and possible financial impact of unfavorable changes in state legislation or a particular state`s economic environment. However, this statement seems to contradict your risk factor on page 17, which discloses that for the six months ended June 30, 2004, approximately 42% of your revenues is concentrated in five states. Please revise your filing to address this apparent contradiction. Summary Consolidated Financial Information - page 8 15. Please revise to clearly label the columns as of and for the six months ended June 30, 2003 as "Unaudited". This comment also applies to the results of operations table on pages 43 and 44. Risk Factors - page 10 16. We note your preamble to the Risk Factors section. The risk factor section should discuss all risks that may materially affect the company and should avoid mentioning generic risks or risks that are not provided sufficient disclosure. Please revise the preamble to clarify that you have discussed all material risks. Also, please remove the last two sentences, or remove the reference to other or immaterial risks, as the fact that the risks facing a business may change is a risk that ever company faces. 17. Please add a risk factor that discusses the fact that due to the distributions that you have made during 2003 and distributions that you plan to complete prior to the offering, that you will have an accumulated deficit at the time of the offering, and so therefore virtually all of the liquidity available for future expansion will come from the unallocated portion of the proceeds from this offering. 18. The Risk Factors section is very long, and many of the risk factors include a significant amount of detail. In fact, many of the risk factors include extensive and verbatim duplication of disclosure included in separate sections. Please revise the risk factors throughout this section so that they briefly describe the risk that an investor would face from investing in your securities, provides information sufficient to place the risk in context and explains the likelihood of the risk occurring and the potential impact of the risk. To the extent that a risk is discussed in more detail elsewhere in the document, consider summarizing the overall impact of the risk in this section and providing a cross-reference to the more detailed discussion in the body of the prospectus. For example, when discussing your litigation exposure, please summarize the number of cases, and the extent of the litigation risk rather than provide summaries of all the cases. 19. Many of your risk factors and their headings warn that the particular risk might have a "material adverse effect" upon your business or operations. The term "material adverse effect" is imprecise and should not be used when the likely effect of a particular risk is fairly predictable. Also, the connection between the specific effects of a risk should clarify how this would affect the value of investors` shares of Advance America, as that is the particular effect of any risk that is most important to the investor. For example, the likely effect of a flaw in your correspondent banks approval process would be an increase in delinquencies and therefore an increase in loan loss charges and a decline in revenue, which might reduce your earnings and therefore harm your share price. Please review all the risk factors to limit your use of the term "material adverse effect" to those situations where the likely impact of a particular risk is not readily ascertainable. 20. The Risk Factors section should present those risks that an investor would face by investing in your company, rather than generic risks that would apply if they invested in any company`s securities. For example, any company`s results would be impacted by declines in the economic conditions in their main markets. Also, all public companies must comply with the Sarbanes Oxley Act, face the risk that analysts might fail to follow their stock or issue unfavorable research, might find their insurance is inadequate and might find that their shares decline in value. Please revise these risk factors so that their specifically address why management believes that these factors present particular risks to an investment in Advance American and its shares. For example, what are your current insurance coverage levels, and how much of your expected losses under workman`s compensation an other expenses do you "self insure?" If you are not able to describe specific reasons that management believes that these risks are unique and material to an investment in your shares, consider removing the risk factors as discussions of generic risks. The payday cash advance services industry is highly regulated under state law - page 10 21. The discussion of the overall risk due to the regulatory environment that your company and industry faces should be separated, and discussed under separate headings, from your discussion of the discrete risk to your operations and earnings from the actions by the State of Georgia and your subsequent decision to suspend operations in the state. Please add a separate risk factor that discusses the specific risks associated with the regulatory developments in Georgia. Also, please add disclosure regarding the actions by the Attorney General of North Carolina that commenced in August 2004 to an appropriate portion of your revised disclosure. Competition in the retail financial services industry... - page 17 22. Revise the discussion of market competition to separate out the risks presented by the fact Republic Bank and Trust has other relations with ACE Cash Express and the fact that this can cost you business. I`m not really sure about this one. It is lopped into a more general risk, but it doesn`t, by itself appear to be worth expanding the RF section, which is already close to 20 pages long. If the lending banks` payday cash advance approval process... - page 18 23. Please revise the heading for this risk factor and the accompanying text to clarify that you retain a significant amount of the credit risk for loans made under the agency model. Customers` personal checks are often returned unpaid... - page 18 24. Revise this risk factor to note the size of your losses on accounts where the customer`s check is returned for insufficient funds. 25. Revise the heading to this risk factor to clarify how the fact that your customers` deposited checks are returned affects your operations and earnings. Being a public company will increase our financial reporting costs... - page 23 26. The Risk Factors section should highlight risks from the perspective of the investor. It would appear that a determination by your auditor that your financial reporting and controls contained a "significant deficiency" would be very important to an investor. Please move this risk factor so that it is discussed at the beginning of the Risk Factors section and revise the heading so that it highlights the risk that you internal controls are in need of improvement. 27. Please supplementally tell us how the significant deficiency in internal controls impacted the auditor`s ability to complete their audit of your financial statements. We expect our costs to increase... - page 25 28. Expand this risk factor to clarify the extent to which you expect your costs to increase. The investor should be able to understand the sources of your increased costs, the likelihood that costs will increase and the effect of those increases. If you do not have specific reason to believe that your costs will increase, so state, and consider removing this risk factor. Also, to the extent that you do have specific reason to believe that your costs will escalate in the future, please differentiate between known cost increases and increases that you believe are possible but are not the result of your growth plans or this offering. Our operating history has no bearing on future profitability... - page 25 29. Please revise this risk factor to clarify why you believe your prior operating history will not be indicative of your future results. Do you plan to undertake new lines of business? Have your operations changed dramatically in the intervening time? If you are not able to point to specific reasons to support this risk factor, please remove it, as it reflects a general risk that your results in the future may suffer. Dividend Policy - page 31 30. We note your disclosure regarding your distributions that have been made, or will occur prior to the offering. We also note that you have a significant amount of restricted cash held by your subsidiaries. Please identify the amount that you would be able to pay in dividends without running afoul of either state law or your debt coven